Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantonic (T89) in Chronic Stable Angina
NCT01659580Phase 3Completed
- Sponsor
- Tasly Group
- Start
- Aug 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of Compound Danshen in angina pectoris, sponsored by Tasly Group. Started Aug 2012; status: completed.
02
Drugs
Compound Danshen
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01659580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659580.